CORC

浏览/检索结果: 共9条,第1-9条 帮助

已选(0)清除 条数/页:   排序方式:
Pazopanib Maintenance Therapy in East Asian Women With Advanced Epithelial Ovarian Cancer: Results From AGO-OVAR16 and an East Asian Study 期刊论文
2018, 卷号: 28, 期号: 1, 页码: 2-10
作者:  Kim, Jae-Weon;  Mahner, Sven;  Wu, Ling-Ying;  Shoji, Tadahiro;  Kim, Byoung-Gie
收藏  |  浏览/下载:6/0  |  提交时间:2020/01/03
Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20 会议论文
作者:  Du Bois, Andreas;  Vergote, Ignace;  Ferron, Gwenael;  Reuss, Alexander;  Meier, Werner
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk 期刊论文
Genetic Epidemiology, 2015, 卷号: 39, 期号: 8
作者:  Amankwah, Ernest K./55638506400[0];  Lin, Huiyi/57043709500[1];  Tyrer, Jonathan P./15045992700[2];  Lawrenson, Kate/26040889200[3];  Dennis, Joe G./56956361900[4]
收藏  |  浏览/下载:30/0  |  提交时间:2019/12/19
Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2014, 卷号: 32, 期号: 30
作者:  du Bois, Andreas;  Floquet, Anne;  Kim, Jae-Weon;  Rau, Joern;  del Campo, Josep M.
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/19
Genome-wide association study (GWAS) of pazopanib efficacy and safety in patients with ovarian cancer who have not progressed following first-line standard therapy. 期刊论文
2014, 卷号: 32, 期号: 15
作者:  Scambia, Giovanni;  Johnson, Toby;  Floquet, Anne;  Heitz, Florian;  Park, Sang-Yoon
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/13
Genome-wide association study (GWAS) of pazopanib efficacy and safety in patients with ovarian cancer who have not progressed following first-line standard therapy. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2014-05-20
作者:  Scambia, Giovanni;  Johnson, Toby;  Floquet, Anne;  Heitz, Florian;  Park, Sang-Yoon
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/13
Randomized, double-blind, phase III trial of pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (AEOC): Results of an international Intergroup trial (AGO-OVAR16). 会议论文
作者:  Du Bois, Andreas;  Floquet, Anne;  Kim, Jae Weon;  Rau, Joern;  Maria Del Campo, Jose
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19
Randomized, double-blind, phase III trial of pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced epithelial ovarian, Fallopian tube, or primary peritoneal cancer (AOC): Results of an international intergroup trial (AGO-OVAR16). 会议论文
作者:  Du Bois, Andreas;  Floquet, Anne;  Kim, Jae Weon;  Rau, Joern;  Del Campo, Jose Maria
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19
A Risk Model for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: An Evidence-Based Proposal for Patient Selection 期刊论文
ANNALS OF SURGICAL ONCOLOGY, 2012, 卷号: 19, 期号: 2
作者:  Tian, Wen-Juan;  Chi, Dennis S.;  Sehouli, Jalid;  Trope, Claes G.;  Jiang, Rong
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/19


©版权所有 ©2017 CSpace - Powered by CSpace